Fertility preservation; Male cancer patients; Oncofertility; Testicular tissue cryopreservation; Testicular tissue transplantation; Spermatogonial stem cells; Sperm cryopreservation; Gonadotoxicity; Assisted reproductive technologies; Oncologic safet

BACKGROUND , including chemotherapy and radiotherapy, may cause temporary or permanent impairment of spermatogenesis and endocrine testicular function. Although Advances in cancer diagnosis and treatment have increased survival rates among male patients, making the preservation of reproductive potential an important component of comprehensive oncological care. However, cancer and gonadotoxic treatmentssperm cryopreservation is an established fertility-preservation strategy for postpubertal males, options remain limited for prepubertal boys and patients unable to provide or retrieve mature sperm before treatment. AIM To review the pathophysiological mechanisms underlying cancer-associated and treatment-induced male reproductive dysfunction, examine established and emerging fertilityoncologic safety challenges of testicular tissue cryopreservation, spermatogonial stem cell transplantation, and testicular tissue transplantation.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24418207
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fertility preservation; Male cancer patients; Oncofertility; Testicular tissue cryopreservation; Testicular tissue transplantation; Spermatogonial stem cells; Sperm cryopreservation; Gonadotoxicity; Assisted reproductive technologies; Oncologic safet

Ivanildo Coutinho de Medeiros
Zenodo (CERN European Organization for Nuclear Research)
Reproductive Biology and Fertility
article

Fertility preservation; Male cancer patients; Oncofertility; Testicular tissue cryopreservation; Testicular tissue transplantation; Spermatogonial stem cells; Sperm cryopreservation; Gonadotoxicity; Assisted reproductive technologies; Oncologic safet

Ivanildo Coutinho de Medeiros
article en

Abstract

BACKGROUND , including chemotherapy and radiotherapy, may cause temporary or permanent impairment of spermatogenesis and endocrine testicular function. Although Advances in cancer diagnosis and treatment have increased survival rates among male patients, making the preservation of reproductive potential an important component of comprehensive oncological care. However, cancer and gonadotoxic treatmentssperm cryopreservation is an established fertility-preservation strategy for postpubertal males, options remain limited for prepubertal boys and patients unable to provide or retrieve mature sperm before treatment. AIM To review the pathophysiological mechanisms underlying cancer-associated and treatment-induced male reproductive dysfunction, examine established and emerging fertilityoncologic safety challenges of testicular tissue cryopreservation, spermatogonial stem cell transplantation, and testicular tissue transplantation.

Zenodo (CERN European Organization for Nuclear Research)
Universidade Federal do Rio Grande do Norte (BR)
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon